Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | -3.59% | -6.00% | -87.23% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.23% | 128M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+53.74% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
+5.99% | 8.31B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- HC Wainwright Adjusts Price Target on Amylyx Pharmaceuticals to $50 From $35, Reiterates Buy Rating